Data from the U.S. Department of Health and Human Services Medicaid Provider Spending database shows that Dallas Medicaid payments totaled at least $68,328 in 2024 for services billed under HCPCS codes specifically tied to COVID-19.
Medicaid is a public health insurance program administered by individual states and funded both by federal and state governments. The program provides coverage for low-income families and individuals, seniors, children, and people with disabilities, making it central to the U.S. health care system.
Since Medicaid funding is taxpayer sourced, fluctuations in local claim totals illustrate how public health care funds are distributed in each community.
COVID-19–related services for this review were determined by identifying HCPCS codes marked as “COVID-19” or “coronavirus” in billing descriptions or within reference documentation. Therefore, the totals only reflect services explicitly logged as COVID-related and do not include other pandemic-driven care that may fall under broader medical codes.
For context, Charlotte saw the highest Medicaid amount for COVID-19–related claims in North Carolina in 2024, reaching $2,373,883 for virus-tied billing.
The data indicates only Caromont Medical Group, Inc filed Medicaid claims for COVID-19–related care in Dallas in 2024.
During the years of the pandemic, Dallas experienced significant Medicaid spending growth attributed to COVID-19–specific services.
Across all other Medicaid claim categories, total payments grew by $968,089 from 2020 to 2024, which is a 167.2% rise.
According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid expenditures totaled approximately $871.7 billion in the 2023 fiscal year, accounting for about 18% of all national health spending. This marked a steep increase from roughly $613.5 billion in 2019, prior to the COVID-19 crisis.
This roughly 40% growth over several years was mainly driven by both expanded program enrollment and increased use during and following the pandemic.
Federal budget legislation enacted during the Trump administration included major plans to reduce federal Medicaid spending and alter its structure. The “One Big Beautiful Bill Act,” signed into law in 2025, is expected to decrease federal Medicaid spending by more than $1 trillion in the next decade and adds new measures such as work requirements and higher cost-sharing, potentially reducing funding and eligibility for some enrollees. These adjustments could place more financial responsibility on states and restrict increases in federal Medicaid support, even as the program continues to cover tens of millions nationwide.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $68,328 | -11.9% | $1,615,417 |
| 2023 | $77,565 | 105.3% | $1,589,033 |
| 2022 | $37,784 | 42.9% | $1,239,915 |
| 2021 | $26,439 | 186.4% | $728,421 |
| 2020 | $9,231 | N/A | $588,231 |
| 2019 | $0 | N/A | $686,395 |
| 2018 | $0 | N/A | $569,866 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87635 | COVID Specific | $37,711 | 905 |
| 87811 | Immunoassay | $30,617 | 879 |
Note: Totals only reflect HCPCS codes explicitly assigned to COVID-19 services; this does not include all pandemic-related health expenditures.
This report is based on information available from the U.S. Department of Health and Human Services Medicaid Provider Spending database, with source data accessible here.
